Patents by Inventor Jill E Wood

Jill E Wood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010034447
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: October 25, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy P. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Rena Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors
    Publication number: 20010027202
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: October 4, 2001
    Inventors: Bernd Riedl, Jaques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010016659
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 23, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Rena Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010011135
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 2, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010011136
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 2, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Raf kinase inhibitors
    Publication number: 20010006975
    Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
    Type: Application
    Filed: January 8, 2001
    Publication date: July 5, 2001
    Applicant: BAYER CORPORATION and ONYX PHARMACEUTICALS West Haven, CT and Richmond, CA, respectively
    Inventors: Jill E. Wood, Hanno Wild, Daniel H. Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger A. Smith, Cheri Blum
  • Inhibition of raf kinase activity using aryl ureas
    Patent number: 6187799
    Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: February 13, 2001
    Assignees: Onyx Pharmaceuticals, Bayer Corporation
    Inventors: Jill E Wood, Hanno Wild, Daniel H Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger A. Smith, Cheri Blum